Literature DB >> 641144

Studies on the mechanism of reduced urinary osmolality after exposure of renal papilla.

E L Chuang, H J Reineck, R W Osgood, R T Kunau, J H Stein.   

Abstract

Studies were performed in Munich-Wistar rats to determine whether changes in papillary plasma flow might be responsible for the concentrating defect which occurs after exposure of the extrarenal papilla. Papillary plasma flow was measured by (125)I-albumin accumulation. Initial studies in hydropenic animals revealed that papillary plasma flow was 40% higher in the kidney with the exposured papilla, 41 vs. 29 ml/min per 100 g of papilla (P < 0.001). This increase in papillary plasma flow was detectable 15 or 45 min after removing the ureter. Because it was unclear whether the rise in papillary plasma flow was a cause or the result of the fall in urine osmolality, similar studies were performed in animals undergoing a water diuresis. In this setting, papillary plasma flow still increased on the exposed side compared to the control side, 81 vs. 60 ml/min per 100 g, despite similarly low urine osmolalities of 155 and 174 mosmol/kg, respectively. This finding is compatible with the possibility that papillary exposure per se causes an increase in papillary plasma flow and that this hemodynamic alteration may lead to a reduction in urinary osmolality secondary to washout of the medullary interstitium. A final group of hydropenic rats was given either indomethacin or meclofenamate before removing the ureter. In these studies, there was no difference in either the papillary plasma flow or the urine osmolality between control and exposed kidneys. It is therefore suggested that opening the ureter induces an increase in papillary plasma flow by some mechanism which may involve an alteration in prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641144      PMCID: PMC372575          DOI: 10.1172/JCI108974

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  OSMOTIC CONCENTRATION AND DILUTION OF THE URINE.

Authors:  C W GOTTSCHALK
Journal:  Am J Med       Date:  1964-05       Impact factor: 4.965

Review 2.  RENAL HEMODYNAMICS.

Authors:  K THURAU
Journal:  Am J Med       Date:  1964-05       Impact factor: 4.965

3.  EFFECT OF PROSTAGLANDIN (PGE-1) ON THE PERMEABILITY RESPONSE OF TOAD BLADDER TO VASOPRESSIN, THEOPHYLLINE AND ADENOSINE 3',5'-MONOPHOSPHATE.

Authors:  J ORLOFF; J S HANDLER; S BERGSTROM
Journal:  Nature       Date:  1965-01-23       Impact factor: 49.962

4.  Blood flow in the renal medulla.

Authors:  L S LILIENFIELD; H C MAGANZINI; M H BAUER
Journal:  Circ Res       Date:  1961-05       Impact factor: 17.367

5.  Dilution and concentration of the urine and the action of antidiuretic hormone.

Authors:  R W BERLINER; N G LEVINSKY; D G DAVIDSON; M EDEN
Journal:  Am J Med       Date:  1958-05       Impact factor: 4.965

6.  Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat.

Authors:  T Berl; A Raz; H Wald; J Horowitz; W Czaczkes
Journal:  Am J Physiol       Date:  1977-06

7.  Effect of prostaglandin E1 on sodium transport and osmotic water flow in the toad bladder.

Authors:  L C Lipson; G W Sharp
Journal:  Am J Physiol       Date:  1971-04

8.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

9.  Direct measurement of papillary collecting duct sodium transport in the rat. Evidence for heterogeneity of nephron function during Ringer loading.

Authors:  J H Stein; R W Osgood; R T Kunau
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin.

Authors:  G M Lum; G A Aisenbrey; M J Dunn; T Berl; R W Schrier; K M McDonald
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more
  15 in total

1.  Solute and water transport along an inner medullary collecting duct undergoing peristaltic contractions.

Authors:  Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

2.  Effect of medullary tonicity on urinary sodium excretion in the rat.

Authors:  H J Reineck; R Parma
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

3.  The mammalian renal pelvis: physiological implications from morphometric analyses.

Authors:  E R Lacy
Journal:  Anat Embryol (Berl)       Date:  1980

4.  Deep nephron function after release of acute unilateral ureteral obstruction in the young rat.

Authors:  J Buerkert; D Martin; M Head; J Prasad; S Klahr
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Studies on the mechanism of sodium excretion during drug-induced vasodilatation in the dog.

Authors:  S Z Fadem; G Hernandez-Llamas; R V Patak; S G Rosenblatt; M D Lifschitz; J H Stein
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

6.  Mechanical simulation of renal pelvic wall peristalsis in the rat.

Authors:  L N Reinking; M C Veale
Journal:  Experientia       Date:  1984-06-15

7.  Urinary concentration in the papillary collecting duct of the rat. Role of the ureter.

Authors:  R E Oliver; D R Roy; R L Jamison
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

8.  Papillary plasma flow in rats. I. Relation to urine osmolality in normal and Brattleboro rats with hereditary diabetes insipidus.

Authors:  F Bayle; L Eloy; M M Trinh-Trang-Tan; J P Grünfeld; L Bankir
Journal:  Pflugers Arch       Date:  1982-09       Impact factor: 3.657

9.  Examination of transepithelial exchange of water and solute in the rat renal pelvis.

Authors:  J Bargman; S L Leonard; E McNeely; C Robertson; R L Jamison
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

10.  Collecting duct sodium reabsorption in deoxycorticosterone-treated rats.

Authors:  J A Haas; T J Berndt; S P Youngberg; F G Knox
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.